{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T09:25:18Z","timestamp":1769937918520,"version":"3.49.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/ijo.2014.2812","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T11:43:01Z","timestamp":1419939781000},"page":"1286-1294","source":"Crossref","is-referenced-by-count":15,"title":["Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer"],"prefix":"10.3892","volume":"46","author":[{"given":"SHANGGE","family":"LV","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOLONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGJUAN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENWEN","family":"QI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAMING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIFENG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"key20180107183520_b1-ijo-46-03-1286","first-page":"71","article-title":"Physiological functions of autophagy","volume":"335","author":"Mizushima","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180107183520_b2-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180107183520_b3-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"key20180107183520_b4-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.coph.2011.03.009","article-title":"The dual role of autophagy in cancer","volume":"11","author":"Eskelinen","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"key20180107183520_b5-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","article-title":"Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis","volume":"10","author":"Degenhardt","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107183520_b6-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107183520_b7-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9873-4","article-title":"Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization","volume":"112","author":"Qadir","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107183520_b8-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"key20180107183520_b9-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"key20180107183520_b10-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"key20180107183520_b11-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","article-title":"TRAIL receptor signalling and modulation: are we on the right TRAIL?","volume":"35","author":"Mahalingam","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"key20180107183520_b12-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2010.519701","article-title":"TRAIL receptor signaling and therapeutics","volume":"14","author":"Abdulghani","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107183520_b13-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-10-2252","article-title":"Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents","volume":"71","author":"Menke","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107183520_b14-ijo-46-03-1286","first-page":"734","article-title":"Chemotherapy augments TRAIL-induced apoptosis in breast cell lines","volume":"59","author":"Keane","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107183520_b15-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1541-7786.MCR-09-0244","article-title":"Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells","volume":"7","author":"Yoshida","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20180107183520_b16-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-008-9924-5","article-title":"TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype","volume":"113","author":"Rahman","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107183520_b17-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/eji.201040591","article-title":"Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses","volume":"41","author":"Bossen","year":"2011","journal-title":"Eur J Immunol"},{"key":"key20180107183520_b18-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"40044","DOI":"10.1074\/jbc.M404541200","article-title":"Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells","volume":"279","author":"Kim","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107183520_b19-ijo-46-03-1286","first-page":"3","article-title":"Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles","volume":"66","author":"Biederbick","year":"1995","journal-title":"Eur J Cell Biol"},{"key":"key20180107183520_b20-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/hmg\/ddn120","article-title":"Premature aging in mice activates a systemic metabolic response involving autophagy induction","volume":"17","author":"Mari\u00f1o","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key20180107183520_b21-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1074\/jbc.M112.395913","article-title":"The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer","volume":"288","author":"Zhang","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180107183520_b22-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"key20180107183520_b23-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4161\/auto.6396","article-title":"Introduction to the review series Autophagy in Higher Eukaryotes - a matter of survival or death","volume":"4","author":"Kelekar","year":"2008","journal-title":"Autophagy"},{"key":"key20180107183520_b24-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107183520_b25-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.yjmcc.2006.03.428","article-title":"Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia\/reperfusion injury","volume":"40","author":"Valentim","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"key20180107183520_b26-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"issue":"Suppl 1","key":"key20180107183520_b27-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.urology.2006.10.041","article-title":"Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer","volume":"69","author":"Sternberg","year":"2007","journal-title":"Urology"},{"key":"key20180107183520_b28-ijo-46-03-1286","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol Cancer Ther"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2812\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:38:42Z","timestamp":1515350322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,30]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/ijo.2014.2812"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2812","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]}}}